MedTrace Logo

Early Warning System for Clinical Deterioration on General Hospital Wards

NCT01280942 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20031

Last updated 2018-02-14

Study results available
· View outcomes & findings →

Summary

The goal is to develop a two-tiered monitoring system to improve the care of patients at risk for clinical deterioration on general hospital wards (GHWs) at Barnes-Jewish Hospital (BJH). The investigators hypothesize that the use of an automated early warning system (EWS) that identifies patients at risk of clinical deterioration, with notification of nurses on the GHWs when patients are identified, will reduce the risk of ICU transfer or death within 24 hrs of an alert. As a substudy, the investigators will pilot the use of a wireless pulse oximeter to establish feasibility and to develop algorithms for a real-time event detection system (RDS) in these high-risk patients.

Conditions

  • Escalation of Care
  • Cardiopulmonary Arrest
  • Respiratory Arrest
  • Severe Sepsis
  • Septic Shock

Interventions

BEHAVIORAL

EWS Nursing Alerts

An automated algorithm (EWS) will identify patients at potential risk of clinical deterioration. When a patient satisfies the algorithm, a nurse on the patient's ward will be notified. S/he will assess the patient and institute any interventions that are clinically required.

DEVICE

Wireless Remote Sensor

A subset of patients will be consented to wear a wireless sensor device which will monitor heart rate and level of oxygen in the blood.

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Thomas C Bailey, MD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01280942 on ClinicalTrials.gov